Share
Embed
microfluidics based chemical separation and reaction schemes
... talk given at Xi'an. 3rd International Symposium on Instrumentation Science and Technology, ISIST, August 18-22, 2004
andreas manz
August 18, 2004
Transcript
60 slides
-
Microfluidics based chemical Microfluidics based chemical separation and reaction schemes
p Andreas Manz Andreas Manz I S A S INSTITUTE FOR ANALYTICAL SCIENCES I S A S INSTITUTE FOR ANALYTICAL SCIENCES Dortmund and Berlin -
l tit l h i t id tif analytitcal chemistry
= identify and quantify molecules and quantify molecules •human genome 3,000,000,000 bases g , , , •proteomics > 100,000 different proteins •metabolomics > 10,000,000 different . small molecules •target: single cell analysis (femtoliter) -
l tit l h i t id tif analytitcal chemistry
= identify and quantify molecules and quantify molecules largest impact in near future: stem cells, g p , cryobiological librairies, tissue engineering, organ engineering completely new medicine organ engineering, completely new medicine -
l tit l h i t id tif analytitcal chemistry
= identify and quantify molecules and quantify molecules example: cell culture p 99% of protein mass is < 20 proteins 1% is the remaining 100 000 1% is the remaining 100,000 difficult -
vision • identify and quantify all compounds in a mixture
(„...omics“) • as a function of time (monitoring) ... as a function of time (monitoring) • ... as a function of space (imaging) -
information t t vision content „...ome“ complex mixture mixture 1
d ti l mixture time 1 times 1 location 1 compound continuously 1/s 1/min 1d 2d 3d space 3d -
information content proteomics glucose sensor most analytical methods time methods
NMR tomography space -
How can we do it ? What will it cost
? h i d i k What time does it take ? -
why miniaturize why miniaturize volume of 1µL 1nL 1pL (1mm)3
(100µm)3 (10µm)3 is a cube of 600,000,000 600,000 600 # molecules (1nM solution) 25 / cm2 2500 / cm2 250 ,000/ cm2 # volumes In array 17 min 10s 100ms diffusion time 1.5 /min / cm2 250 /s / cm2 2,500,000 /s / cm2 # reactions (diffusion controlled) (diffusion controlled) -
How about 100 nm scale (cube)? •Limitation to >mM concentration
•Limitation to molecular weight < 100 000 100,000 •Time scale is fast enough at 1 um g scale -
What do we have now? What do we have now?
[example 1] [example 1] • Electrophoresis chips - Caliper Electrophoresis chips Caliper, Agilent, Hitachi, Shimadzu etc. i l d f A f • mainly used for DNA fragment sizing • protein separations bi • bioassays -
10 fold miniaturization 100 x faster separation p 1000 x
smaller volume 10 x lower reagent consumption -
electrophoresis p c e [ a r b . u
n i t s ] 1 2 3 4 c y c l e # t 7 s s y n c h r . c e [ a r b . u n i t s ] 1 2 3 4 c y c l e # t 7 s s y n c h r . c e [ a r b . u n i t s ] 1 2 3 4 c y c l e # t 7 s s y n c h r . f l u o r e s c e n 0 4 0 8 0 1 2 0 1 6 0 5 6 7 8 f l u o r e s c e n 0 4 0 8 0 1 2 0 1 6 0 5 6 7 8 f l u o r e s c e n 0 4 0 8 0 1 2 0 1 6 0 5 6 7 8 -
nano channels & single molecules 80 x 80 nm channel
bulk DNA L.C.Campbell, M.J.Wilkinson, A.Manz, P.Camilleri, C.J.Humphreys -
What do we have now? What do we have now?
[example 2] [example 2] • Reactor chips - Upchurch, Ehrfeld etc. etc. • Mainly used for solvent di t i h t h gradients in chromatography • Chemical synthesis y • Bioassays -
F. G. Bessoth, Dissertation, Imperial College, 2000. F. G. Bessoth,
A. J. deMello, A. Manz, Anal. Commun., 1999, 36, 6, 213-215. -
chemical reactor Micromixer chip / PTFE interface PTFE interface Inlet
capillaries Syringes Injection loop Rheodyne injection valve Injection loop outlet capillary -
H R1 O M OH Cl- R1 Multicomponent Chemistries: The
Ugi Reaction N+ H H R R2 Cl- H H MeOH N+ Cl H2 O R2 R1/R2 = -CH2 (CH2 )3 CH2 - + + Piperidinium cation Formaldehyde 0oC R3 R /R CH2 (CH2 )3 CH2 Piperidine hydrochloride Piperidinium cation y (1) (2) (3) N R4 C R3 R3 R3/R4 = -CH2 (CH2 )4 CH2 - R1 N R4 H2 O R1 N N R4 O + 2 ( 2 )4 2 Cyclohexyl isocyanide (4) N R2 R2 Nitrilium intermediate -Dialkylacetamide N-Cyclohexyl-2-piperidin-1-yl-acetamide Nitrilium intermediate (5) (6) -
Simultaneous Observation of Reactants, Intermediates, Products and By-products 20 L
i 1 20 Lmin-1 50 nL injection loop Room temperature -
Set-up for NMR measurement NMR Detection coil Micromixer (200m i.d.)
Syringe pumps y g p p 250m i.d. 75m i.d. -
NMR set-up NMR NMR 3m Capillary Syringe pump Sweedler group,
Univ. of Illinois -
Hi 68 Tyr59 A His68 N N A 10 L/min
(24sec) N N A 40 L/min (6sec) A (6sec) Sweedler group, group, Univ. of Illinois -
DNA hybridisation assays DNA hybridisation assays contribution to Fluorescence contribution
to Fluorescence Intercalating dye alone low DNA oligomers low Oligomer dimers medium dsDNA high dsDNA high -
influence of DNA sequence on influence of DNA sequence on
kinetics kinetics Order: t hi 1 matching, 1 mismatch, 2 mismatches Sequence-dependent responses from two different experiments. -
microfluidic DNA assays 1 d t d i i •
1 second to decision • no complicated surface chemistry • no complicated surface chemistry • sensitivity 100-200nM sensitivity 100 200nM • could be competing with DNA arrays -
What would I address? What would I address? [example 1]
[example 1] protein separations by free-flow electrophoresis y p … isoelectric focusing -
IEF hi IEF chip • 36 x 20 um inlet
channels • 72 x 20 um outlet channels h id 108 4 h l • each side 108 x 4 um channels • separation bed 12.2 x 4.1 mm p – 15,552 posts 30 x 30 um – 30 x 30 um -
comparison p FFE FFE c e [ a r b
. u n i t s ] 1 2 3 4 c y c l e # t 7 s s y n c h r . c e [ a r b . u n i t s ] 1 2 3 4 c y c l e # t 7 s s y n c h r . c e [ a r b . u n i t s ] 1 2 3 4 c y c l e # t 7 s s y n c h r . f l u o r e s c e n 0 4 0 8 0 1 2 0 1 6 0 5 6 7 8 f l u o r e s c e n 0 4 0 8 0 1 2 0 1 6 0 5 6 7 8 f l u o r e s c e n 0 4 0 8 0 1 2 0 1 6 0 5 6 7 8 CE -
I l t i f i Isoelectric focusing • charge
of protein molecule depends on pH g p p p • low pH (acidic): protein is cation hi h H (b i ) t i i i • high pH (basic): protein is anion • generate a pH gradient across electric field g p g – ions move until overall charge is zero isoelectric point is different for each protein – isoelectric point is different for each protein -
IEF f f i i l IEF proof of principle
12 mm angiotensin I, 1.75 kV, 10 uL/min g o e s , .75 V, 0 u / 4 mm = 500 ms 4 mm = 500 ms 4 mm 0 mm -
IEF t i IEF - proteins angiotensin I, 1.75 kV,
10 uL/min g o e s , .75 V, 0 u / -
IEF hi IEF chip • volume 240 nL plus wells
p • at 10 uL/min 1 4 d (ti t i f ti ) – 1.4 seconds (time to information) • preconcentration 100 - 400x -
What would I address? What would I address? [example 2]
[example 2] air quality monitor by plasma emission spectroscopy y p p py gas chromatography -
detector plasma emission detector volume 50 L p 50 nL
J.C.T.Eijkel, H.Stoeri, A.Manz, J. Anal. At. Spectrom. 15, 297-300 p , (2000) -
plasma emission CH2 Cl2 p 4000 4500 CH2 Cl2 CH
He He H He 3500 4000 Cl 2500 3000 n s ity (A U ) 2000 is s io n In te n CCl C/C2 1000 1500 Em 0 500 C2 0 200 300 400 500 600 700 800 900 Wavelength (nm) -
calibration for methane calibration for methane J.C.T.Eijkel, H.Stoeri, A.Manz Anal.
Chem. 71, 2600-2606 (1999) d i li i 2 10 14 / C • detection limit 2·10-14 g/s C 4 U. 104 ound / A. 1000 us backgro 100 nsity minu sion inten 3*Noise 10 1 10 100 1000 emiss CH 4 concentration / ppm -
CONCLUSIONS • Reactions and separations benefit from h t ti
l i i h shorter timescales, micro is enough • Detection schemes usually suffer, but to y different extents, nano is quite difficult • Integration / small volumes advantageous, Integration / small volumes advantageous, below 1 nL doesn’t matter • More commercial products in near future • More commercial products in near future, but micro scale -
Acknowledgment g my Imperial College team my new ISAS team
Joachim Franzke Norbert Jakubowski Jan Eijkel Gareth Jenkins Norbert Jakubowski Philip Day Yi Xu Chao-Xuan Zhang Valerie Spikmans Martin Heule Jörg Baumbach Volker Deckert g Michael Mitchell Fi B h Dirk Janasek L C b ll Roland Hergenröder N b E Fiona Bessoth Lucy Campbell Norbert Esser Kay Niemax, Prof. -
Acknowledgment funding g Glaxo SmithKline (UK) Glaxo SmithKline (UK) AstraZeneca
(UK) EU research grant Casect Ltd. (UK) ( ) Swiss National Science Foundation (Switzerland) EPSRC grant (UK) Leopoldina (Germany)